These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9346856)

  • 1. Structure-activity relationships and physico-chemical properties of synthetic lipopeptide inhibitors of PKC.
    Hussain R; Sergheraert C; Drake AF; Siligardi G
    Biomed Pept Proteins Nucleic Acids; 1995; 1(2):69-72. PubMed ID: 9346856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the cAMP-dependent protein kinase by synthetic A-helix peptides.
    Gamboni S; Chaperon C; Friedrich K; Baehler PJ; Reymond CD
    Biochemistry; 1998 Sep; 37(35):12189-94. PubMed ID: 9724532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of a new C-myristylamido peptide exerting potent and selective PKC inhibitory activity.
    Zaliani A; Gromo G; Pinori M; Mascagni P
    Drug Des Discov; 1996 Apr; 13(3-4):63-74. PubMed ID: 8874044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes.
    Roth A; Espuelas S; Thumann C; Frisch B; Schuber F
    Bioconjug Chem; 2004; 15(3):541-53. PubMed ID: 15149182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage isomerism in the binding of pentapeptide Ac-His(Ala)3His-NH2 to (ethylenediamine)palladium(II): effect of the binding mode on peptide conformation.
    Hoang HN; Bryant GK; Kelso MJ; Beyer RL; Appleton TG; Fairlie DP
    Inorg Chem; 2008 Oct; 47(20):9439-49. PubMed ID: 18788796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide substrate-based affinity label blocks protein kinase C-catalyzed ATP hydrolysis and peptide-substrate phosphorylation.
    Ward NE; Pierce DS; Stewart JR; O'brian CA
    Arch Biochem Biophys; 1999 May; 365(2):248-53. PubMed ID: 10328819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function correlation and biostability of antibody CDR-derived peptides as tumour imaging agents.
    Hussain R; Courtenay-Luck NS; Siligardi G
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):67-70. PubMed ID: 9575342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly potent and selective PKCalpha inhibitor generated via combinatorial modification of a peptide scaffold.
    Lee JH; Nandy SK; Lawrence DS
    J Am Chem Soc; 2004 Mar; 126(11):3394-5. PubMed ID: 15025445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
    Harris JM; McIntosh EM; Muscat GE
    J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
    Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
    J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition by alpha and epsilonPKC pseudosubstrate sequences: a putative mechanism for preferential PKC activation in neonatal cardiac myocytes.
    Johnson JA
    Life Sci; 2004 May; 74(25):3153-72. PubMed ID: 15081580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moiety.
    Lai YS; Mendoza JS; Jagdmann GE; Menaldino DS; Biggers CK; Heerding JM; Wilson JW; Hall SE; Jiang JB; Janzen WP; Ballas LM
    J Med Chem; 1997 Jan; 40(2):226-35. PubMed ID: 9003521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic characteristics of a Ser/Thr protein kinase, SpkA, from Myxococcus xanthus.
    Kimura Y; Kakemizu A; Matsubara Y; Takegawa K
    J Biosci Bioeng; 2009 Jan; 107(1):10-5. PubMed ID: 19147102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characterization and topology of the second potential membrane anchor region in the thromboxane A2 synthase amino-terminal domain.
    Ruan KH; Li D; Ji J; Lin YZ; Gao X
    Biochemistry; 1998 Jan; 37(3):822-30. PubMed ID: 9454571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms.
    van der Merwe JQ; Moreau F; MacNaughton WK
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1258-66. PubMed ID: 19359428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.
    Inagaki K; Hahn HS; Dorn GW; Mochly-Rosen D
    Circulation; 2003 Aug; 108(7):869-75. PubMed ID: 12860903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model peptides mimic the structure and function of the N-terminus of the pore-forming toxin sticholysin II.
    Casallanovo F; de Oliveira FJ; de Souza FC; Ros U; Martínez Y; Pentón D; Tejuca M; Martínez D; Pazos F; Pertinhez TA; Spisni A; Cilli EM; Lanio ME; Alvarez C; Schreier S
    Biopolymers; 2006; 84(2):169-80. PubMed ID: 16170802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays.
    Poot AJ; van Ameijde J; Slijper M; van den Berg A; Hilhorst R; Ruijtenbeek R; Rijkers DT; Liskamp RM
    Chembiochem; 2009 Aug; 10(12):2042-51. PubMed ID: 19618415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein.
    Corradin S; Ransijn A; Corradin G; Bouvier J; Delgado MB; Fernandez-Carneado J; Mottram JC; Vergères G; Mauël J
    Biochem J; 2002 Nov; 367(Pt 3):761-9. PubMed ID: 12137567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.